Patient Information Leaflet

Spasmofree 5 mg/ 2 ml ampoules for I.M or I.V. Diclonerve capsules for relief of pain and inflammation ADWIPRAZOLE (Aripiprazole 10, 30 mg) tablets Vegapantin 800mg dividable tablets bisected and trisected Randil Tablets – Nicorandil 10 mg, 20 mg Antiflu Capsule Anticox II Tablets & Capsules Amadol 100 Ampoule – Tramadol Hcl Ketoprof 200 ER capsules Adwiflam 75 mg Injection – Adwiflam 50 mg Capsules Anticox II Suppositories, Tablets, Capsules & Ampoules Profenazone Capsules – MUSCLE RELAXANT Osteonate Tablets – osteoporosis in postmenopausal women & pagets disease. Doxy MR Capsules – ANTI-INFECTIVE Trustnal 500 mg Film Coated Tablet – Trustnal 100 mg /5 ml Powder for oral suspension Itranox Capsules – Broad Spectrum Antifungal Derminafine Cream – Topical Antifungal Osmoran Tablets Epiran 75 Tablets Acicard Tablets  Hepatic Forte Capsules Binorec Tablets Microfiber Tablets Antiflu Capsules Butaline E.R. Capsules Ambrodoxy Capsules Danset Ampoules Uripan Syrup & Tablets V

ADWIA- United Arab Emirates , El Ein ADWIA Agents: Bin Sughan Est., P.O.Box 19942 Hilton Street Tel : 97137510575 & 009713750557 . More information from: ADWIA S.A.E. – Egyptian Company for Chemicals & Pharmaceuticals

 Warning against use in children: Rivo 75 should not be used in children under 16 years of age. What if you are pregnant, think you may be pregnant, or plan to become pregnant? Rivo 75 is not associated with any problems during pregnancy except during childbirth, but like all medicines, it is necessary to consult a doctor or pharmacist to know if Rivo 75 is suitable for you. It should not be used in the last three months of pregnancy due to the possibility of acetylsalicylic acid causing prolongation of delivery with increased bleeding before and after childbirth and the possibility of causing disruption of the blood clotting process in the newborn baby. How do I take Rivo 75 mg? Usually the daily dose is 1 to 2 tablets once daily. Sometimes a higher dose may be needed, especially for a short period of up to 4 tablets per day. More Info about Rivo 75 mg https://pharmacily.com/rivo-75-mg-chewable-tablets/

 Cinnarizine quickly relieves symptoms caused by circulatory disorders in the brain and extremities and prevents vascular headache attacks such as migraine. It restores blood circulation in the brain to normal in terms of its time and graph, and improves blood flow in patients who suffer from a disorder and in patients who suffer from vascular spasms (Raynaud's disease), as it restores arterial pulses to normal.  This drug significantly increases the velocity of the arterial impulses and blood flow in severely injured limbs and increases walking distances in patients with intermittent cramps in the legs.  Cinnarizine helps speed up the healing of leg ulcers. It also reduces or eliminates symptoms of inner ear disorders such as vertigo, tinnitus and symptoms of the autonomic nervous system (nausea - throwing up - pallor and coldness of the extremities) and prevents or reduces their occurrence in the future. More info about  Cinnarizine

 COMPOSITION Each Cerebromap 100 mg capsule contains: 100 mg naftidrofuryl oxalate.  Each Cerebromap 200 mg capsule contains: 200 mg naftidrofuryl oxalate. PHARMACOLOGICAL ACTION Pharmacodynamics: Naftidrofuryl oxalate has been shown to exert a direct effect on intracellular metabolism, thus it has been shown in man and animals that it produces an increase of ATP levels and a decrease of lactic acid levels in ischemic conditions, evidence for an enhancement of cellular oxidative capacity. Furthermore, naftidrofuryl oxalate is a powerful spasmolytic agent. At vascular level: Naftidrofuryl, an antivasoconstrictor (not a vasodilator) agent, increases blood flow by lowering arteriolar tone. At tissue level: Naftidrofuryl locally opposes the vasoconstricting and platelet pro-aggregant actions of serotonin by blocking 5 HT2 receptors, explaining the clinical antivasoconstrictor effect and the improvement of blood flow in ischemic areas without including systemic hypotension. Naftidrofuryl e

 COMPOSITION Olapex 5 mg: Olanzapine 5 mg.  Olapex 10 mg: Olanzapine 10 mg. PROPERTIES Olanzapine has shown a broad pharmacological effect across a number of receptor systems. Olanzapine demonstrates greater affinity for serotonin receptors as well as dopamine receptors.  Olanzapine is well absorbed after oral administration and reaches peak plasma concentration within 6 hours. The absorption is not affected by food. Olanzapine is metabolized in the liver and the mean terminal half-life is 30 hours. INDICATIONS Olanzapine is indicated for acute and maintenance treatment of short term schizophrenia and other psychosis where positive and / or negative symptoms are prominent.  Olanzapine also alleviates the secondary disorders. DOSAGE & ADMINISTRATION The recommended daily dose is 10 mg once daily adjusted to usual range 5-20 mg daily.  Doses of 15 mg or greater should be given only after reassessment.  Starting dose of 5 mg per day is considered for geriatric patients and patients wi

COMPOSITION Each film coated tablet contains: 1200 mg piracetam. PHARMACOLOGICAL ACTION Oxitropil contains piracetam which acts selectively on the central nervous system by different mechanisms.  Piracetam improves the function of the neurotransmitter which is implicated in memory & learning process. Piracetam increases the energy out of the brain cells especially in deficit condition.  Piracetam improves cerebral blood flow and microcirculation on account of its hemorheological properties without causing vasodilation. It has also been found to increase oxygen consumption in parts of the brain. INDICATIONS Oxitropil is indicated in the following: Cerebrovascular Pathology related to aging: memory deficit, decrease in intellectual efficiency and concentration, adaptation disorders disturbed psychomotor reactions. Cerebrovascular insufficiency. Post stroke. Post traumatic syndrome: cerebral dysfunction related to post traumatic sequelae (Headache, vertigo and agitation) Symptomatic r

COMPOSITION Each tablet 20/12.5 mg contains 20 mg olmesartan medoxomil + 12.5 mg hydrochlorothiazide. Each tablet 40/12.5 mg contains 40 mg olmesartan medoxomil + 12.5 mg hydrochlorothiazide. Inactive: Lactose, colloidal silicon dioxide, maize starch, magnesium stearate, red iron oxide, yellow iron oxide, methocel, talc, titanium dioxide. PHARMACOLOGICAL ACTION Angiotensin II is the principal pressor agent of the renin-angiotensin system with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation and renal re-absorption of sodium. Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle. Its action is, therefore, independent of the pathways for angiotensin II synthesis. Hydrochlorothiazide acts by removing the excess water from the body by increasing the production of urine consequently reducing the volume of fluids circulat

Composition Each tablet contains carvedilol 6.25 mg or 25 mg. PROPERTIES Carvedilol, the active ingredient in CARVID, is a cardioprotective non cardio selective beta adrenoceptor blocking drug (beta-blocker) which has in addition an arteriolar vasodilating action by alpha 1 receptor blocking effect, and thus lowers peripheral resistance. INDICATIONS 1 • .Essential hypertension. 2 • Angina pectoris. 3 • Chronic heart failure adjunct to diuretics, digoxin, or ACE inhibitors. 4• Left ventricular dysfunction following acute myocardial infarction. DOSAGE AND ADMINISTRATION Hypertension:  Initially 12.5 mg once daily or individualized increased after 3 days to the usual dose 25 mg once daily or individualized. If necessary may be further increased at intervals of at least 7 to 14 days to maximum daily dose of 50 mg given once a day or in divided doses. The full antihypertensive effect of CARVID is seen within 7 to 14 days. Angina pectoris:  Initially 12.5 mg twice daily, increased after 2 da